Clinical Trial Update: Lenalidomide Following Fludarabine/Rituximab (FR) in Untreated Chronic Lymphocytic Leukemia (CLL) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating lenalidomide after fludarabine/rituximab in untreated chronic lymphocytic leukemia has completed with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia

Drugs mentioned

• Lenalidomide (lenalidomide)
• fludarabine/rituximab

Snippet

Sponsor: Georgetown University | Conditions: Chronic Lymphocytic Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2014-08-18